iKids-Growth
Commercial- Indications
- Short stature, Growth disorders, Silver-Russell Syndrome, SHOX Deficiency
Company intelligence / Profile preview
Agebox has developed a range of functional dietary supplements targeting pediatric growth, neurodevelopmental disorders, metabolic conditions, and aging. Their lead product, iKids-Growth capsules, is commercially available and designed to enhance IGF‑1 production and utilization for optimal bone growth. Clinical studies are ongoing for certain indications such as Silver-Russell Syndrome intervention with positive early results reported anecdotally; however, no peer-reviewed clinical trial data is yet published.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Agebox.